Peptide for cancer
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
66
NCT04260529
CyPep-1 Injections in Cancer Inducing Lymphocyte Infiltrate Accumulations
Phase: Phase 1/2
Role: Lead Sponsor
Start: Apr 30, 2020
Completion: Jul 5, 2024
NCT05383170
A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers
Start: Mar 21, 2023
Completion: Sep 23, 2024
Loading map...